Cargando…
The prognostic effect of immunosuppressive therapy in IgA nephropathy with stage 3 or 4 chronic kidney disease
BACKGROUND: It is debated whether patients with IgAN with heavy proteinuria and decreased eGFR benefit from aggressive treatment consisting of corticosteroids alone or combined with immunosuppressive agents. METHODS: A retrospective study was performed between January 2008 and December 2016 on patie...
Autores principales: | Yang, Xiaoxia, Ma, Feng, Bai, Ming, Wang, Yan, Jia, Qing, Dong, Ruijuan, Liu, Chunmei, Sun, Shiren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366668/ https://www.ncbi.nlm.nih.gov/pubmed/34376108 http://dx.doi.org/10.1080/0886022X.2021.1956536 |
Ejemplares similares
-
Effect of corticosteroids combined with cyclophosphamide or mycophenolate mofetil therapy for IgA nephropathy with stage 3 or 4 chronic kidney disease: A retrospective cohort study
por: Jia, Qing, et al.
Publicado: (2022) -
Helicobacter pylori infection is associated with elevated galactose-deficient IgA1 in IgA nephropathy
por: Liu, Xing-Zi, et al.
Publicado: (2020) -
Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
por: Chen, Pei, et al.
Publicado: (2018) -
Alleviation of refractory IgA nephropathy by intensive fecal microbiota transplantation: the first case reports
por: Zhao, Jin, et al.
Publicado: (2021) -
Hydroxychloroquine in IgA nephropathy: a systematic review
por: Stefan, Gabriel, et al.
Publicado: (2021)